If we assume 6-7 million each quarter,
price going lower with each dilution
about a year from now until the end of phase 1 (which is what anzalone said they will need for RNAI partnerships)
share offerings will get done without problems, and they will get the money they need.
current market cap of 30M
that's about 100% dilution from where we are today.
You are not very well informed...
They have cash till about june. And they will get quite a few... mio. $ for the 5 ongoing phase 1 trails from Cerulean. And also for the new IND clx_301 and more mio. $ for a partnership Cerulean with a big pharma player. And maybe more $ for sublicensing...
So they will have enough till the end of this year.
And I am not including a possible big RNAi-partnership for ARWR...
I don't mind some dilution! As long as they stay independent, the more they will get after ARC-520 phase I.